|1.||Miyoshi, Eiji: 2 articles (10/2006 - 08/2002)|
|2.||Taniguchi, Naoyuki: 2 articles (10/2006 - 08/2002)|
|3.||Zhang, Min: 1 article (09/2015)|
|4.||Chen, Xuemei: 1 article (09/2015)|
|5.||Wang, Meirong: 1 article (09/2015)|
|6.||Liu, Xueqing: 1 article (09/2015)|
|7.||Gao, Rufei: 1 article (09/2015)|
|8.||Wang, Yingxiong: 1 article (09/2015)|
|9.||Ding, Yubin: 1 article (09/2015)|
|10.||He, Junlin: 1 article (09/2015)|
|1.||Hepatocellular Carcinoma (Hepatoma)
01/01/2001 - "Expression of bisecting N-acetylglucosaminyltransferase-III in human hepatocarcinoma tissues, fetal liver tissues, and hepatoma cell lines of Hep3B and HepG2."
06/01/1998 - "Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma."
11/24/1995 - "Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611."
09/14/1990 - "The N-acetylglucosaminyltransferase III activity toward the substrate is the highest in most rat tissues including primary rat hepatoma. "
09/14/1990 - "N-Acetylglucosaminyltransferase III, IV and V activities were assayed in various rat tissues and hepatomas using the same fluorescence-labeled sugar chain, GlcNAc beta 1-2Man alpha 1-3-(GlcNAc beta 1-2Man alpha 1-6)Man beta 1-4GlcNAc beta 1-4GlcNAc-2-aminopyridine as a substrate. "
|2.||Neoplasm Metastasis (Metastasis)
09/12/1995 - "Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection."
07/01/1995 - "[Suppression of lung metastasis of B16 mouse melanoma cells by introduction of N-acetylglucosaminyltransferase III gene]."
07/15/2009 - "N-acetylglucosaminyltransferase III (GnT-III) catalyzes the formation of a bisecting GlcNAc structure in N-glycans, and has been pointed as a metastasis suppressor. "
10/27/2006 - "N-acetylglucosaminyltransferase III (GnT-III) catalyzes the formation of a bisecting GlcNAc structure in N-glycans, resulting in the suppression of metastasis. "
11/15/2003 - "Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III."
08/01/2002 - "In order to understand the biological effects of N-acetylglucosaminyltransferase III (GnT-III) on tumor formation in the liver, diethylnitrosamine (DEN) induced tumor formation in the GnT-III transgenic mice was examined. "
06/15/2000 - "New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice."
11/15/2003 - "Mice lacking N-acetylglucosaminyltransferase III (GlcNAc-TIII) exhibit slightly but significantly retarded liver tumor progression after a single injection of 10 micro g/g diethylnitrosamine (DEN) and continued administration of phenobarbital (PB) in drinking water. "
08/01/2002 - "A glycomic approach to hepatic tumors in N-acetylglucosaminyltransferase III (GnT-III) transgenic mice induced by diethylnitrosamine (DEN): identification of haptoglobin as a target molecule of GnT-III."
|4.||Melanoma (Melanoma, Malignant)
|5.||Liver Cirrhosis (Hepatic Cirrhosis)
06/01/1998 - "N-Acetylglucosaminyltransferase III activity from the HCC group (153 +/- 72pmol/mL/h) was significantly higher than that from liver cirrhosis (99 +/- 67 pmol/mL per h), chronic hepatitis (84 +/- 39 pmol/mL per h) and the normal controls (62 +/- 16 pmol/mL per h). "
12/15/1989 - "N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients."
|6.||N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)
|7.||Apolipoprotein A-I (Apolipoprotein A1)
|8.||Uridine Diphosphate (UDP)
|9.||Messenger RNA (mRNA)
|10.||RNA-Directed DNA Polymerase (Reverse Transcriptase)